Skip to content

Prospective Randomized Trial of Fruits or Nuts Eaten Between Regular Meals in Healthy Subjects

Prospective Randomized Trial of Fruits or Nuts Eaten Between Regular Meals in Healthy Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02227511
Enrollment
27
Registered
2014-08-28
Start date
2014-08-31
Completion date
2015-05-31
Last updated
2016-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects

Keywords

fruit, nuts, liver fat, insulin, glucose, Focus of the study is to compare the often given advice to eat fruit, containing large amount of glucose and fructose, with nuts that are more rich in fat.

Brief summary

Recruitment of 28 subjects that will be randomized to consume fruit or nuts as snacks between regular meals for two months. Laboratory tests for cardiovascular risk factors, metabolic rate, liver steatosis and physical activity are investigated ahead of start of the study and at the end of the trial period och two months. Participants will be allowed to buy fruits or nuts on their own but to keep track (diaries) of the amount consumed. They will be reimbursed for the costs of the snacks.

Interventions

DIETARY_SUPPLEMENTFruits

Randomization to extra fruit or nuts as snacks

DIETARY_SUPPLEMENTNuts

Sponsors

University Hospital, Linkoeping
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 76 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy subjects

Exclusion criteria

* significant diseases that can affect outcomes, mental disorders that can affect participation.

Design outcomes

Primary

MeasureTime frameDescription
amount of fat in the liver by magnetic resonance imagingtwo monthsexact measurement of fat in the liver by liver spectroscopy

Secondary

MeasureTime frameDescription
cardiovascular risk factorstwo monthsCollection of markers for cardiovascular risk including glucose, insulin, lipoproteins etc. Analyses will be performed from blood samples.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026